Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Baxter Deutschland, Österreich, SchweizBaxter Deutschland, Österreich, Schweiz
VS
MANKIND PHARMA LTDMANKIND PHARMA LTD
Baxter Deutschland, Österreich, Schweiz

Baxter Deutschland, Österreich, Schweiz

Edisonstraße 4, Unterschleißheim, 85716, DE

Last Update: 27/12/2025

View Profile
Between 750 and 799
https://www.baxter.de/de
754/1000Fair

Unsere Produkte und Therapien werden täglich von Millionen Menschen weltweit angewendet. Sie sind überall dort im Einsatz, wo Leben gerettet und wieder lebenswert gemacht werden: in Krankenhäusern, Arztpraxen und bei den Menschen zu Hause. Patienten und Ärzte vertrauen ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:30
12-month incidents
0
Known data breaches
0
Attack type number
0
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Phase 3, New Delhi, IN

Last Update: 06/09/2026

View Profile
Between 750 and 799
http://www.mankindpharma.com
781/1000Fair

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:19,230
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Baxter Deutschland, Österreich, Schweiz

Baxter Deutschland, Österreich, Schweiz

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MANKIND PHARMA LTD

MANKIND PHARMA LTD

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Baxter Deutschland, Österreich, Schweiz in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents

Incident History - Baxter Deutschland, Österreich, Schweiz (X = Date, Y = Severity)

Baxter Deutschland, Österreich, Schweiz cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MANKIND PHARMA LTD (X = Date, Y = Severity)

MANKIND PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Baxter Deutschland, Österreich, Schweiz

Baxter Deutschland, Österreich, Schweiz

Incidents
No explicit notable incidents reported.
MANKIND PHARMA LTD

MANKIND PHARMA LTD

Incidents
No explicit notable incidents reported.

FAQ

Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has the best AI Cybersecurity Score ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents in the past ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced more cyber incidents this year ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced at least one ransomware attack ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced at least one data breach ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced at least one targeted cyberattack ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has experienced at least one vulnerability ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one holds the most compliance certifications ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one holds the fewest compliance certifications ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has the most subsidiaries ?
Between Baxter Deutschland, Österreich, Schweiz company and MANKIND PHARMA LTD company, which one has the largest number of employees ?
Between Baxter Deutschland, Österreich, Schweiz and MANKIND PHARMA LTD, which company holds both SOC 2 Type 1 certifications ?
Between Baxter Deutschland, Österreich, Schweiz and MANKIND PHARMA LTD, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Baxter Deutschland, Österreich, Schweiz or MANKIND PHARMA LTD ?
Which company is PCI DSS compliant - Baxter Deutschland, Österreich, Schweiz or MANKIND PHARMA LTD ?
Between Baxter Deutschland, Österreich, Schweiz and MANKIND PHARMA LTD, which company complies with HIPAA regulations for healthcare data ?
Between Baxter Deutschland, Österreich, Schweiz and MANKIND PHARMA LTD, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-86544
SUMMARY

knowns versions before 0.30.0 contain an authorization bypass vulnerability where mutating code actions are incorrectly classified as read-only operations. Attackers with read-restricted sessions can exploit code.replace to modify permission configurations and escalate privileges on subsequent calls.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.1)
CVSS3
Base Score: 8.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
2.8
CVE-2026-86543
SUMMARY

knowns versions before 0.30.0 serve the management API without authentication on all network interfaces by default, with no password required on fresh installations. Attackers can access the unauthenticated /api/tunnel/start endpoint to provision a public tunnel and republish the API at a publicly accessible address.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-86542
SUMMARY

knowns before 0.30.0 fails to validate import names in the import routes, allowing unauthenticated attackers to write files outside the imports directory. Attackers can supply traversal sequences in the name parameter to escape the imports directory and overwrite arbitrary files writable by the server process.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-86541
SUMMARY

knowns versions before 0.30.0 contain a path traversal vulnerability in the handleCodeReplace() function that allows attackers to overwrite arbitrary files outside the project root. Attackers can supply absolute paths or relative paths containing directory traversal sequences to write malicious content to sensitive files like shell startup scripts or SSH configuration files.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 8.3)
CVSS3
Base Score: 8.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:H/A:H
CVSS4
Base Score: 7.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.5
EXPLOITABILITY
2.8
CVE-2026-86540
SUMMARY

knowns versions before 0.30.0 fail to validate the settings.lsp.languages binary field in project configuration files, allowing attackers to execute arbitrary binaries by crafting a malicious .knowns/config.json file. When a repository with a crafted configuration is opened, the unvalidated binary path is executed twice under the user's account without any verification.

PUBLISHED
Date2026-09-07
UPDATED
Date2026-09-07
RISK INFORMATION (Score: 7.8)
CVSS3
Base Score: 7.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.5
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
1.8